Skip to content

A randomized controlled trial of intravitreal conbercept injection for exudative senile macular degeneration'patients of intraocular lens eye and phakic eye

The otherness of intravitreal conbercept injection for exudative senile macular degeneration'patients of intraocular lens eye and phakic eye

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16009597
Enrollment
Unknown
Registered
2016-10-25
Start date
2016-10-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

exudative senile macular degeneration

Interventions

intraocular lens eye and phakic eye single treatment group:conbercept intravitreal injection
intraocular lens eye and phakic eye thrice treatment group:conbercept intravitreal injection

Sponsors

The First People's Hospital of Yunnan Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. According to clinical test,FFA,ICGA and OCT test,which are conform to the diagnostic criteria of exudative AMD; 2. Accept the treament of intravitreal conbercept injection; 3. Accepted tests regularly and follow-up time over 3 months; 4. Excluding the serious cardio-pulmonary-cerebral,liver and kidney diseases; 5. The intra-oculopathy except for AMD.

Exclusion criteria

Exclusion criteria: 1. The patients which had accepted others treatments and surgery; 2. AMD is inactive; 3. The whole body combined with the serious cardio-pulmonary-cerebral diseases and liver and kidney diseases; 4. Besides AMD,the patients has others intraocular diseases; 5. The patients had the history of eyes; 6. The patients which had accepted the cataract surgery because of non-age related cataract, or who had aphakic eye and incomplete lens posterior capsule; 7. The patients can't accepts the treament plan or follow-up visits.

Design outcomes

Primary

MeasureTime frame
BCVA;CRT;CMT;SRF;CNV;Lesions area of the exudative senile macular degeneration;

Countries

China

Contacts

Public ContactXiaochun Yang

The First People's Hospital of Yunnan Province

blackstone502@163.com+86 15808825607

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026